Chapter 20 - COMPOUNDING PRACTICES

State Regulations
Compare

Rule 657-20.1 - Purpose and scope
Rule 657-20.2 - Definitions
Rule 657-20.3 - Nonsterile compounding
Rule 657-20.4 - Sterile compounding
Rule 657-20.5 - Delayed compliance
Rule 657-20.6 - Compounding standards for outsourcing facilities
Rule 657-20.7 - Reserved
Rule 657-20.8 - Reserved
Rule 657-20.9 - Prescriber/patient/pharmacist relationship
Rule 657-20.10 - Anticipatory compounding
Rule 657-20.11 - Prohibition on resale of compounded preparations
Rule 657-20.12 - Compounding copies of an approved drug
Rule 657-20.13 - Use of flavoring agents
Rule 657-20.14 - Reserved
Rule 657-20.15 - Compounding for office use
Rule 657-20.16 - Compounding for hospital use
Rule 657-20.17 - Reserved
Rule 657-20.18 - Reserved
Rule 657-20.19 - Labeling
Rule 657-20.20 - Labeling for batch preparation compounding
Rule 657-20.21 - Reserved
Rule 657-20.22 - Reserved
Rule 657-20.23 - [Effective until 10/26/2022] Records
Rule 657-20.23 - [Effective 10/26/2022] Records, version 2
Rule 657-20.24 - Annual reporting of interstate distribution of compounded preparations

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.